Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Ayrton of Ghana Reaches 10-Week High on Strategic Investor Stake

April 20 (Bloomberg) -- Ayrton Drug Manufacturing Ltd., a manufacturer of pharmaceutical products in Ghana, rose to the highest since Feb. 3 on speculation a “strategic investor” acquired a stake in the company.

The stock gained 1 pesewa, or 6.3 percent, to close at 17 pesewas as of 2:40 p.m. in the capita, Accra.

“A strategic investor was taking a position in the company,” Hilary Lomotey, a trader with Renaissance Capital said in a telephone interview from Accra, declining to give details. “The person has an interest in a pharmaceuticals company and Ayrton Drug is the biggest in terms of market capitalization on Ghana’s market.”

To contact the editor responsible for this story: Antony Sguazzin at asguazzin@bloomberg.net.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.